FlightPath (Drug Discovery)
Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infectious bacteria in Lyme disease to limit microbiome damage and treat multiple pathogen...
Valuation
$21M
Latest known
Share Price
N/A
Total Raised
$9.7M
Last Round
N/A